158 related articles for article (PubMed ID: 30567092)
21. Challenges in the treatment of parathyroid carcinoma: a case report.
Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid cancer.
Fang SH; Lal G
Endocr Pract; 2011; 17 Suppl 1():36-43. PubMed ID: 21454239
[TBL] [Abstract][Full Text] [Related]
23. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
[TBL] [Abstract][Full Text] [Related]
24. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
[TBL] [Abstract][Full Text] [Related]
25. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.
Yu W; McPherson JR; Stevenson M; van Eijk R; Heng HL; Newey P; Gan A; Ruano D; Huang D; Poon SL; Ong CK; van Wezel T; Cavaco B; Rozen SG; Tan P; Teh BT; Thakker RV; Morreau H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E360-4. PubMed ID: 25387265
[TBL] [Abstract][Full Text] [Related]
26. Update on parathyroid carcinoma.
Cetani F; Pardi E; Marcocci C
J Endocrinol Invest; 2016 Jun; 39(6):595-606. PubMed ID: 27001435
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.
Yip L; Seethala RR; Nikiforova MN; Nikiforov YE; Ogilvie JB; Carty SE; Yim JH
Surgery; 2008 Dec; 144(6):949-55; discussion 954-5. PubMed ID: 19041002
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid carcinoma: an overview.
DeLellis RA
Adv Anat Pathol; 2005 Mar; 12(2):53-61. PubMed ID: 15731573
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid carcinoma: biochemical and pathologic response to DTIC.
Calandra DB; Chejfec G; Foy BK; Lawrence AM; Paloyan E
Surgery; 1984 Dec; 96(6):1132-7. PubMed ID: 6505966
[TBL] [Abstract][Full Text] [Related]
30. Genetic profiling as a clinical tool in advanced parathyroid carcinoma.
Kutahyalioglu M; Nguyen HT; Kwatampora L; Clarke C; Silva A; Ibrahim E; Waguespack SG; Cabanillas ME; Jimenez C; Hu MI; Sherman SI; Kopetz S; Broaddus R; Dadu R; Wanland K; Williams M; Zafereo M; Perrier N; Busaidy NL
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1977-1986. PubMed ID: 31309300
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid Carcinoma: A Single-Institution Experience with an Emphasis on Histopathological Features.
Sali AP; Motghare P; Bal M; Mittal N; Rane S; Kane S; Patil A
Head Neck Pathol; 2021 Jun; 15(2):544-554. PubMed ID: 33151464
[TBL] [Abstract][Full Text] [Related]
32. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and morphological characteristics of parathyroid carcinoma].
Voronkova IA; Mokrysheva NG; Kazantseva IA; Gurevich LE
Arkh Patol; 2018; 80(4):65-72. PubMed ID: 30059074
[TBL] [Abstract][Full Text] [Related]
34. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.
Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review.
Roser P; Leca BM; Coelho C; Schulte KM; Gilbert J; Drakou EE; Kosmas C; Ling Chuah L; Wassati H; Miras AD; Crane J; Aylwin SJB; Grossman AB; Dimitriadis GK
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36621911
[TBL] [Abstract][Full Text] [Related]
36. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of parathyroid cancer.
Schulte KM; Talat N
Nat Rev Endocrinol; 2012 Oct; 8(10):612-22. PubMed ID: 22751344
[TBL] [Abstract][Full Text] [Related]
38. Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma.
Chang YJ; Mittal V; Remine S; Manyam H; Sabir M; Richardson T; Young S
Am Surg; 2006 May; 72(5):419-26. PubMed ID: 16719197
[TBL] [Abstract][Full Text] [Related]
39. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]